Back

Weekly Journal Scan: SELECT renoprotective effects of semaglutide in non-diabetic, obese patients with cardiovascular disease

European Heart Journal

4 September 2024
Organised by: Logo
Read full article
ESC Journals

Contributors

Rocco Vergallo
Rocco Vergallo

Author

Massimo Volpe
Massimo Volpe

Author

Sapienza University of Rome Rome , Italy

You may be interested in
thumbnail
Congress Presentation
Evidence for cardio-renal protection through weight reduction
30 August 2024
thumbnail
ESC TV Today
Episode 18: Heart disease risk: Framingham Heart Study insights - Sudden death in female athletes
19 June 2025
thumbnail
Congress Presentation
Effect of oral semaglutide on CV outcomes across the vascular disease spectrum, from no vascular disease to polyvascular disease, in high-risk type 2 diabetes
1 September 2025
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources